---
source_pdf_path: Resources/s41746-025-02198-6.pdf
slug: ma-2025-virtual-cell-models
ledger_status: TRIAGED
---

# ma-2025-virtual-cell-models

## Bibliographic
- Title: AI-driven virtual cell models in preclinical research: technical pathways, validation mechanisms, and clinical translation potential
- First author / authors (first 3 + et al.): Chunyu Ma, Han Zhang, Yiwei Rao, et al.
- Year: 2025
- Venue: npj Digital Medicine
- DOI: 10.1038/s41746-025-02198-6

## One-line claim
A review of AI-driven virtual cell models that integrate multimodal omics data and deep learning to predict drug responses, gene perturbations, and disease progression, with emphasis on validation mechanisms, regulatory challenges, and clinical translation.

## T6 targeted questions
- **Q-A geometry perturbation**: NOT REPORTED. Models operate at single-cell molecular/genetic level; no geometric or anatomical perturbation.
- **Q-B decision flip**: NOT REPORTED. No discussion of binary diagnostic thresholds or reclassification outcomes.
- **Q-C BC tuning**: NOT REPORTED. No boundary condition tuning or compensation for structural model errors.
- **Q-D fidelity / quantity**: NOT REPORTED. Cellular-level computational models without spatial CFD or hemodynamic fields.
- **Q-E data**: NOT REPORTED. Discusses integration of omics data (transcriptomics, proteomics) and organoid validation but no specific cohort sizes, datasets, or ground truth.
- **Q-F meshing**: NOT REPORTED. No segmentation, meshing, or geometric robustness discussion.

## Novelty bearing on T6
- bucket: IRRELEVANT
- one-line reason: Virtual cell models operate at subcellular/molecular scale for drug discovery; no relevance to coronary imaging, segmentation, or hemodynamic validation.
- possible-other-project: Computational biology for drug discovery and personalized medicine
- verdict: LIGHT
- revisit-if: If T6 incorporates multi-scale (molecular to hemodynamic) uncertainty propagation frameworks.
